Background Image
Table of Contents Table of Contents
Previous Page  2 / 64 Next Page
Information
Show Menu
Previous Page 2 / 64 Next Page
Page Background

AMLOC 5, 10 mg.

Each tablet contains amlodipine maleate equivalent to 5, 10 mg amlodipine respectively. S3 A38/7.1/0183, 0147. NAM NS2 06/7.1/0011, 0012. BOT S2 BOT 0801198, 0801199. For full prescribing

information, refer to the professional information approved by SAHPRA, 29 September 2017.

1)

IMS MAT Units Feb 2019.

2)

Dahlof B, Sever PS, Poulter NR,

et al.

for the Ascot investigators. Prevention of cardiovascular

events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering

Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Lancet

2005;366:895-906.

3)

Nissen SE,

et al.

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood

pressure. The CAMELOT study: A randomised controlled trial.

JAMA

2004;292:2217-2226.

ACH592/04/2019.

WHEN ALL THE PARTS FIT...

EFFICACY

2

SAFETY

2

PROVEN OUTCOMES

3

PERFECTLY.

For further product information contact

PHARMA DYNAMICS

P O Box 30958 Tokai Cape Town 7966

Fax

+27 21 701 5898

Email

info@pharmadynamics.co.za

CUSTOMER CARE LINE

0860 PHARMA (742 762) / +27 21 707 7000

www.pharmadynamics.co.za